Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic Dermatitis

This study has been completed.
Information provided by:
Novartis Identifier:
First received: July 14, 2005
Last updated: January 10, 2008
Last verified: January 2008
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2007
  Estimated Primary Completion Date: No date given